Login / Signup

Dura promotes metastatic potential in prostate cancer through the CXCR2 pathway.

Michael J StrongSabrina RoccoRussell S TaichmanGregory A ClinesNicholas J Szerlip
Published in: Journal of neuro-oncology (2021)
DCM enhances the metastatic potential of PCa with increased proliferation, migration and invasion. This phenomenon is partly mediated through the CXCR2 pathway.
Keyphrases
  • prostate cancer
  • squamous cell carcinoma
  • small cell lung cancer
  • human health
  • signaling pathway
  • cell migration
  • risk assessment
  • climate change